Proposed Data Collections Submitted for Public Comment and Recommendations

Federal RegisterSep 2, 1999

Ask Donna

What actually matters in this document.

Text

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[INFO-99-28]

Proposed Data Collections Submitted for Public Comment and

Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for opportunity for public comment on

proposed data collection projects, the Centers for Disease Control and

Prevention (CDC) will publish periodic summaries of proposed projects.

To request more information on the proposed projects or to obtain a

copy of the data collection plans and instruments, call the CDC Reports

Clearance Officer on (404) 639-7090.

Comments are invited on: (a) Whether the proposed collection of

information is necessary for the proper performance of the functions of

the agency, including whether the information shall have practical

utility; (b) the accuracy of the agency's estimate of the burden of the

proposed collection of information; (c) ways to enhance the quality,

utility, and clarity of the information to be collected; and (d) ways

to minimize the burden of the collection of information on respondents,

including through the use of automated collection techniques for other

forms of information technology. Send comments to Seleda Perryman, CDC

Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24,

Atlanta, GA 30333. Written comments should be received within 60 days

of this notice.

Proposed Project

Translating Research Into Action for Diabetes (TRIAD)--New--The

National Center for Chronic Disease Prevention and Health Promotion

(NCCDPHP), Division of Diabetes Translation. Diabetes exerts a huge

public health burden, and there are several efficacious interventions

to combat the effects of this disease. Yet, the quality of care and

quality of life among people with diabetes remain sub-optimal in the

United States. The Centers for Disease Control and Prevention, Division

of Diabetes Translation, intends to conduct a multi-center study called

Translating Research Into Action for Diabetes (TRIAD). This study will

assess quality of diabetes care and identify effective means of

applying existing knowledge to improve care and quality of life. Data

provided from TRIAD will be critical to the Division of Diabetes

Translation's ongoing efforts to reduce the burden of diabetes.

Data will be collected through cooperative agreements with six

[[Page 48180]]

Managed Care Organizations (MCOs). Each MCO will provide data on

organization of care, details of diabetes interventions, and efforts to

improve diabetes care collected from interviews of health plan and

provider group directors. Each MCO will also provide data from random

samples of its diabetic members collected via computer-assisted

telephone interviews (CATIs). Information from plan members will

include demography, quality of diabetes care, quality of life,

satisfaction with care, diabetes severity and duration, and barriers to

care. Each MCO will collect data from directors and diabetic members at

baseline and after two years of follow-up. The total cost to

respondents is estimated at $1,620,000.

----------------------------------------------------------------------------------------------------------------

Number of Avg. burden of

Respondent Number of respondents responses/ response (In Total burden

respondent hrs.) (In hrs.)

----------------------------------------------------------------------------------------------------------------

Managed Care Organizations (MCOs)..... 6 MCOs--(each respondent 2 0.75 27,000

MCO will provide

information from an

average of 3,000 plan

members and directors).

-------------------------------------------------------------------------

Total............................. ........................ .............. .............. 27,000

----------------------------------------------------------------------------------------------------------------

Dated: August 24, 1999.

Nancy Cheal,

Acting Associate Director for Policy, Planning and Evaluation, Centers

for Disease Control and Prevention (CDC).

[FR Doc. 99-22860 Filed 9-1-99; 8:45 am]

BILLING CODE 4163-18-P

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.